Document is current
Any future updates will be listed below
-
Authors
Hein, Victoria
Baeza-Kallee, Nathalie
Bergès, Raphaël
Essakhi, Nora
Soubéran, Aurélie
Colin, Carole
Morando, Philippe
Appay, Romain
Graillon, Thomas
Tchoghandjian, Aurélie
Figarella-Branger, Dominique
Tabouret, Emeline
-
Funding
Funding for this research was provided by:
ARTC-Sud
Canceropôle Provence-Alpes-Côte d’Azur
Institut National Du Cancer
Région Sud
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 13 April 2025
First Online: 2 July 2025
Declarations
:
: GBM IDHwt human tumour samples were collected at Assistance Publique-Hôpitaux de Marseille (AP-HM) during neurosurgery resection, prior chemotherapy and radiotherapy, and placed in Hank’s Balanced Salt Solution (HBSS). Samples were obtained from the centre of biological resources of AP-HM (CRB BB-0033-00097) according to a protocol approved by the local institutional review board and ethics committee (2014-A00585–42) and conducted according to national regulations. The study was performed in accordance with the declaration of Helsinki. All the patients provided written informed consent. All experimental procedures and animal care were carried out in accordance with the guidelines of the French Government, reviewed and approved by the Regional Institutional Committee for Ethics on Animal Experiments under the authorization number 33388-2021100616089494.
: Not applicable.
: The authors declare no competing interests.
